Triangle Securities Wealth Management’s GSK GSK Stock Holding History

Triangle Securities Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-6,055	Closed	-$328K	–	124
2016 Q2	$328K	Sell	6,055 -1,159	-16%	-$61.1K	0.24%	97
2016 Q1	$366K	Sell	7,214 -89	-1%	-$4.43K	0.24%	101
2015 Q4	$368K	Sell	7,303 -2,300	-24%	-$117K	0.25%	91
2015 Q3	$462K	Sell	9,603 -280	-3%	-$14.6K	0.35%	87
2015 Q2	$515K	Sell	9,883 -299	-3%	-$16.8K	0.36%	81
2015 Q1	$587K	Sell	10,182 -216	-2%	-$12.4K	0.41%	79
2014 Q4	$556K	Sell	10,398 -2,197	-17%	-$123K	0.4%	78
2014 Q3	$724K	Sell	12,595 -775	-6%	-$47.5K	0.56%	67
2014 Q2	$894K	Buy	13,370 +2,844	+27%	+$193K	0.68%	55
2014 Q1	$617K	Sell	10,526 -416	-4%	-$28.1K	0.55%	63
2013 Q4	$730K	Buy	10,942 +60	+0.6%	+$3.89K	0.59%	64
2013 Q3	$682K	Sell	10,882 -332	-3%	-$21.4K	0.59%	64
2013 Q2	$700K	Buy	+11,214	New	+$712K	0.52%	61

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Triangle Securities Wealth Management's GSK Position: Q3 2016 in Review

Triangle Securities Wealth Management sold out of GSK (GSK) in Q3 2016, closing a stake of 6,055 shares — an estimated $328K sold.

Triangle Securities Wealth Management first reported a position in GSK in Q2 2013 and held it in 13 quarters. The position peaked at $894K in Q2 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

Triangle Securities Wealth Management reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
Triangle Securities Wealth Management sold 6,055 GSK shares in Q3 2016, an estimated $328K.
Triangle Securities Wealth Management first reported a position in GSK in Q2 2013 and held it in 13 quarters.
Triangle Securities Wealth Management's GSK position peaked at $894K in Q2 2014.
740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Triangle Securities Wealth Management's 13F filing for Q3 2016, filed 6 Oct 2016.